6thDRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE:

An Intensive Course on Translating Research into Drugs


Presented by the Alzheimer's Drug Discovery Foundation

February 12-14, 2012 ●  New York, NY









The Drug Discovery for Neurodegeneration conference advances drug discovery for neurodegenerative diseases by educating scientists on the process of translating basic research into novel therapies.

The course is designed to give participants knowledge and relevant resources about this field of scientific investigation and address the associated barriers and challenges.

The program will focus on Alzheimerís disease, Parkinsonís disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis.


COURSE OBJECTIVES

1. Train a cadre of interdisciplinary scientists in the principles of drug discovery for neurodegenerative disease

2. Provide a platform to exchange ideas, knowledge and resources about drug discovery for neurodegenerative disease

3. Stimulate pre-clinical research in the discovery and testing of novel compounds aimed at the prevention and treatment of neurodegenerative disease

4. Build public-private partnerships that will accelerate drug discovery for neurodegenerative disease.

2011 MEETING SUMMARY
Click here to review the 2011 meeting summary along with session details, presentations, speakers, etc.
WHAT YOU WILL LEARN

   Fundamentals of medicinal chemistry for biologists

   Basics of high-throughput screening and assay development

   Optimizing lead compounds and conducting in vivo efficacy and safety studies

   Utilizing animal models in preclinical development

   Requirements for an Investigational New Drug (IND) application

   Designing drugs for CNS target classes

   Working efficiently with technology transfer offices

   Intellectual property strategy: commercial potential, protectability and patentability

   Best practices and lessons learned

   Accessing resources and funding

SCIENTIFIC ADVISORY COMMITTEE

Kurt R. Brunden, PhD, University of Pennsylvania

Neil Buckholtz, PhD, National Institute on Aging

Rebecca Farkas, PhD, National Institute of Neurological Disorders and Stroke

Howard Fillit, MD, Alzheimerís Drug Discovery Foundation

Brian Fiske, PhD, Michael J. Fox Foundation for Parkinsonís Research

Mark Frasier, PhD, Michael J. Fox Foundation for Parkinsonís Research

Abram Goldfinger, MBA, New York University

Lorenzo Refolo, PhD, National Institute on Aging

Suzana Petanceska, PhD, National Institute on Aging

Diana Shineman, PhD, Alzheimerís Drug Discovery Foundation

Edward G. Spack, PhD, Fast Forward, LLC

D. Martin Watterson, PhD, Northwestern University

TARGET AUDIENCE

Academic and industry scientists engaged in drug discovery research for neurodegenerative disease or CNS

Business development and licensing professionals

Alliance management professionals

Young investigators and graduate students

ARCHIVED PROGRAMS

All pages will open in new windows:

2011 Program

2010 Program

2009 Program

2008 Program

2007 Program

WEBCASTS

The 2012 Drug Discovery for Neurodegeneration Conference presentations are available on demand.

Click here to view the webcasts of:

 

2012

2011

2010.

  Share

 
The Drug Discovery for Neurodegeneration conference is presented by the Alzheimer's Drug Discovery Foundation (ADDF), the only public charity solely dedicated to rapidly accelerating the discovery and development of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging.